TOKYO--(BUSINESS WIRE)--Philips Respironics GK (Headquartered in Minato Ward of Tokyo, hereafter Philips, CEO Danny Risberg) announced today that, beginning April 1, 2014, they are starting sales of a ...

Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

The U.S. Food and Drug Administration on Friday announced the recall of certain Philips Respironics devices designed to help people with breathing conditions keep breathing at a regular rhythm. The ...

Dutch manufacturer Philips has agreed to pay $1.1 billion to settle lawsuits regarding some models of its devices to treat sleep apnea, the company announced Monday. The settlement comes after a three ...

1) Excluding provisions charged to sales of EUR 174 million in Q4 2023 mainly in connection with the Respironics consent decree. Roy Jakobs, CEO of Royal Philips: “Our strong results in 2023 were ...

Issues with ventilators across three major manufacturers—Philips, Baxter and Zoll—have led to a string of Class I recall notices from the FDA, the agency’s most severe level. First, a serious problem ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...